These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 12167283)

  • 1. Toward improved evaluation of cytotoxic T-lymphocyte (CTL)-inducing HIV vaccines in Thailand.
    Ariyoshi K; Promadej N; Ruxrungtham K; Sutthent R
    AIDS Res Hum Retroviruses; 2002 Jul; 18(10):737-9. PubMed ID: 12167283
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced sensitivity of detection of cytotoxic T lymphocyte responses to HIV type 1 proteins using an extended in vitro stimulation period for measuring effector function in volunteers enrolled in an ALVAC-HIV phase I/II prime boost vaccine trial in Thailand.
    Kantakamalakul W; De Souza M; Karnasuta C; Brown A; Gurunathan S; Birx D; Thongcharoen P; Taveg T
    AIDS Res Hum Retroviruses; 2004 Jun; 20(6):642-4. PubMed ID: 15242541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV vaccine efficacy trials: towards the future of HIV prevention.
    Kim D; Elizaga M; Duerr A
    Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific activation strategies for amplification of low CTL signals.
    Weinhold KJ; Tartaglia J; Paoletti E; Graham B; Schwartz D; McElrath J; Roberts N; Gorse G
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1373. PubMed ID: 1466958
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV escape from cytotoxic T lymphocytes: a potential hurdle for vaccines?
    Barouch DH; Letvin NL
    Lancet; 2004 Jul 3-9; 364(9428):10-1. PubMed ID: 15234837
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults.
    Gorse GJ; Baden LR; Wecker M; Newman MJ; Ferrari G; Weinhold KJ; Livingston BD; Villafana TL; Li H; Noonan E; Russell ND;
    Vaccine; 2008 Jan; 26(2):215-23. PubMed ID: 18055072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V3 CTL epitope density in a single recombinant molecule antigen differentially affects the number and activity of primary and memory CD8+ T cells.
    Lu L; Zhu Y; Diao J; Wang Z; Chen YH
    Vaccine; 2008 Feb; 26(6):845-52. PubMed ID: 18191003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment.
    Calarota SA; Leandersson AC; Bratt G; Hinkula J; Klinman DM; Weinhold KJ; Sandström E; Wahren B
    J Immunol; 1999 Aug; 163(4):2330-8. PubMed ID: 10438897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T-lymphocyte responses to canarypox vector-based HIV vaccines in HIV-seronegative individuals: a meta-analysis of published studies.
    Edupuganti S; Weber D; Poole C
    HIV Clin Trials; 2004; 5(5):259-68. PubMed ID: 15562366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytotoxic T-lymphocyte response in HIV-1 infection.
    Kalams SA; Walker BD
    Clin Lab Med; 1994 Jun; 14(2):271-99. PubMed ID: 7924192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Despite snags and skepticism, Thai vaccine trial lumbers on.
    Padma TV
    Nat Med; 2004 Dec; 10(12):1267. PubMed ID: 15580234
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV vaccines. Viral envelope fails to deliver?
    Bolognesi DP; Matthews TJ
    Nature; 1998 Feb; 391(6668):638-9. PubMed ID: 9490406
    [No Abstract]   [Full Text] [Related]  

  • 13. Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct.
    Cardinaud S; Bouziat R; Rohrlich PS; Tourdot S; Weiss L; Langlade-Demoyen P; Burgevin A; Fiorentino S; van Endert P; Lemonnier FA
    AIDS; 2009 Sep; 23(15):1945-54. PubMed ID: 19644347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
    Fomsgaard A; Karlsson I; Gram G; Schou C; Tang S; Bang P; Kromann I; Andersen P; Andreasen LV
    Vaccine; 2011 Sep; 29(40):7067-74. PubMed ID: 21767590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from natural infection: focusing on the design of protective T cell vaccines for HIV/AIDS.
    Ahlers JD; Belyakov IM
    Trends Immunol; 2010 Mar; 31(3):120-30. PubMed ID: 20089450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers.
    Gorse GJ; Patel GB; Belshe RB;
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1175-89. PubMed ID: 11522187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
    Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
    Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary in vitro generation of cytotoxic cells specific for human minor histocompatibility antigens between HLA-identical siblings.
    Tekolf WA; Shaw S
    J Immunol; 1984 Apr; 132(4):1756-60. PubMed ID: 6199410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.
    Miskovsky EP; Liu AY; Pavlat W; Viveen R; Stanhope PE; Finzi D; Fox WM; Hruban RH; Podack ER; Siliciano RF
    J Immunol; 1994 Sep; 153(6):2787-99. PubMed ID: 7915742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.